Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JANX Janux Therapeutics, Inc.

交易中 07-29 09:54:26 EDT

25.36

-0.19

-0.74%

最高25.68	最低25.28	成交量8.51万
今开25.63	昨收25.55	日振幅1.57%
总市值15.01亿	流通市值9.40亿	总股本5,918万
成交额216.49万	换手率0.23%	流通股本3,706万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"JANX","market":"US","secType":"STK","nameCN":"Janux Therapeutics, Inc.","latestPrice":25.36,"timestamp":1753797262747,"preClose":25.55,"halted":0,"volume":85084,"delay":0,"floatShares":37063690,"shares":59175157,"eps":-1.365404,"marketStatus":"交易中","change":-0.19,"latestTime":"07-29 09:54:26 EDT","open":25.63,"high":25.68,"low":25.28,"amount":2164894.8233040003,"amplitude":0.015656,"askPrice":25.37,"askSize":100,"bidPrice":25.32,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-1.365404,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753819200000},"marketStatusCode":2,"adr":0,"listingDate":1623384000000,"exchange":"NASDAQ","adjPreClose":25.55,"preHourTrading":{"tag":"盘前","latestPrice":26,"preClose":25.55,"latestTime":"09:27 EDT","volume":112,"amount":2919.4393760000003,"timestamp":1753795660058},"postHourTrading":{"tag":"盘后","latestPrice":25.36,"preClose":25.55,"latestTime":"19:08 EDT","volume":74219,"amount":1896277.27,"timestamp":1753744126675},"volumeRatio":1.608216,"impliedVol":0.74,"impliedVolPercentile":0.188},"requestUrl":"/m/hq/s/JANX","defaultTab":"news","newsList":[{"id":"2537647770","title":"Janux Therapeutics, Inc.盘中异动 下午盘股价大涨5.09%报25.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537647770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537647770?lang=zh_cn&edition=full","pubTime":"2025-05-21 02:08","pubTimestamp":1747764492,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日02时08分，Janux Therapeutics, Inc.股票出现异动，股价急速拉升5.09%。截至发稿，该股报25.40美元/股，成交量50.1097万股，换手率0.85%，振幅6.37%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020812a485b654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020812a485b654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4139","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2536584248","title":"Janux Therapeutics, Inc.2025财年第一财季实现净利润-23.51百万美元，同比减少59.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536584248","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536584248?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497640,"startTime":"0","endTime":"0","summary":"5月18日，Janux Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-23.51百万美元，同比减少59.28%；其中营业收入为0.00美元，每股基本收益为-0.38美元。机构评级：截至2025年5月18日，当前有11家机构对Janux Therapeutics, Inc.目标价做出预测，其中目标均价为88.55美元，其中最低目标价为36.00美元，最高目标价为200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000309a6e2d89e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000309a6e2d89e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","LENZ"],"gpt_icon":0},{"id":"2536317075","title":"Janux Therapeutics, Inc.盘中异动 大幅上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536317075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536317075?lang=zh_cn&edition=full","pubTime":"2025-05-16 23:50","pubTimestamp":1747410622,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日23时50分，Janux Therapeutics, Inc.股票出现波动，股价大幅上涨5.11%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为4355.29%、2589.82%、1345.31%，振幅较大的相关个股有Affimed N.V.、Onconetix, Inc.、Vor Biopharma Inc.，振幅分别为466.98%、66.89%、66.82%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051623502294f9256a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051623502294f9256a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2535712378","title":"Janux Therapeutics, Inc.盘中异动 股价大涨5.26%报23.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535712378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535712378?lang=zh_cn&edition=full","pubTime":"2025-05-16 01:13","pubTimestamp":1747329182,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日01时13分，Janux Therapeutics, Inc.股票出现波动，股价急速拉升5.26%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.93%。其相关个股中，Abpro Holdings, Inc、Nucana Plc、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃，换手率分别为12480.18%、5020.79%、360.07%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Renovaro Inc.、Nucana Plc，振幅分别为76.92%、68.18%、63.87%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516011303aa2c9053&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516011303aa2c9053&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","JANX","LENZ","BK4007"],"gpt_icon":0},{"id":"2535073082","title":"Janux Therapeutics, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535073082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535073082?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:56","pubTimestamp":1747231012,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时56分，Janux Therapeutics, Inc.股票出现波动，股价急速跳水5.01%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，蓝鸟生物、Septerna, Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2730.24%、1936.07%、1375.91%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Rani Therapeutics Holdings, Inc.、Traws Pharma, Inc.，振幅分别为46.33%、42.33%、31.97%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421565294f6cd35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421565294f6cd35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","BK4007","JANX"],"gpt_icon":0},{"id":"2534514205","title":"Janux Therapeutics, Inc.盘中异动 早盘股价大涨6.30%报27.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534514205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534514205?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:32","pubTimestamp":1747056739,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分，Janux Therapeutics, Inc.股票出现波动，股价大幅拉升6.30%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为285.50%、60.41%、58.49%，振幅较大的相关个股有Athira Pharma, Inc.、Imunon, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为12.86%、10.00%、8.51%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213225a47b76cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213225a47b76cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","JANX","BK4007","LENZ"],"gpt_icon":0},{"id":"2533134933","title":"Janux Therapeutics, Inc.盘中异动 急速下跌5.31%报24.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533134933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533134933?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:52","pubTimestamp":1746712368,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时52分，Janux Therapeutics, Inc.股票出现波动，股价快速跳水5.31%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.08%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Nucana Plc、Gri Bio, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为360.11%、52.94%、21.80%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Monte Rosa Therapeutics, Inc.、Vor Biopharma Inc.，振幅分别为28.00%、20.65%、17.83%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821524897534e3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821524897534e3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","JANX"],"gpt_icon":0},{"id":"2533304415","title":"Janux Therapeutics, Inc.盘中异动 急速下挫9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533304415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533304415?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:31","pubTimestamp":1746451888,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时31分，Janux Therapeutics, Inc.股票出现波动，股价急速跳水9.09%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Nucana Plc涨幅较大，Nucana Plc、Scisparc Ltd.、Aptevo Therapeutics Inc.较为活跃，换手率分别为675.67%、253.74%、42.91%，振幅较大的相关个股有Polyrizon Ltd.、Nucana Plc、Scisparc Ltd.，振幅分别为19.82%、17.41%、11.76%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213128a6d3e117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213128a6d3e117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","JANX"],"gpt_icon":0},{"id":"2532000468","title":"Janux Therapeutics, Inc.盘中异动 股价大跌5.03%报31.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532000468?lang=zh_cn&edition=full","pubTime":"2025-05-02 00:18","pubTimestamp":1746116319,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日00时18分，Janux Therapeutics, Inc.股票出现异动，股价急速下跌5.03%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Transcode Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Hookipa Pharma Inc.涨幅较大，Transcode Therapeutics, Inc.、Onconetix, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为273.12%、83.56%、53.90%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为43.70%、40.07%、31.76%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502001839a46f1289&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502001839a46f1289&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4139","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2530151273","title":"Janux Therapeutics, Inc.盘中异动 临近午盘大幅下跌5.24%报30.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530151273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530151273?lang=zh_cn&edition=full","pubTime":"2025-04-25 23:54","pubTimestamp":1745596446,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日23时54分，Janux Therapeutics, Inc.股票出现异动，股价急速下挫5.24%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Jaguar Health, Inc.涨幅较大，Azitra Inc、Tnf Pharmaceuticals, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为264.74%、186.37%、112.46%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Coeptis Therapeutics Holdings, Inc.，振幅分别为90.48%、48.68%、38.57%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425235406a466ff6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425235406a466ff6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2529681395","title":"Janux Therapeutics, Inc.盘中异动 股价大涨6.10%报31.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529681395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529681395?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415084,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分，Janux Therapeutics, Inc.股票出现异动，股价快速上涨6.10%。截至发稿，该股报31.84美元/股，成交量8177股，换手率0.01%，振幅0.33%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213125aa2c77fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213125aa2c77fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","JANX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2529324580","title":"Janux Therapeutics, Inc.盘中异动 早盘大幅上涨5.02%报30.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529324580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529324580?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:43","pubTimestamp":1745329386,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时43分，Janux Therapeutics, Inc.股票出现波动，股价急速上涨5.02%。截至发稿，该股报30.77美元/股，成交量1.4117万股，换手率0.02%，振幅3.69%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214306a6c3dd54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214306a6c3dd54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","JANX","BK4007","LENZ"],"gpt_icon":0},{"id":"2526619819","title":"Janux Therapeutics, Inc.盘中异动 下午盘快速拉升5.06%报28.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526619819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526619819?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:39","pubTimestamp":1744393190,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时39分，Janux Therapeutics, Inc.股票出现波动，股价急速拉升5.06%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2116.98%、1634.75%、398.77%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412013951aa2c6d18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412013951aa2c6d18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","JANX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2517430499","title":"Janux Therapeutics, Inc.2024财年实现净利润-68.99百万美元，同比减少18.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430499?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363252,"startTime":"0","endTime":"0","summary":"3月8日，Janux Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-68.99百万美元，同比减少18.36%；其中营业收入为10.59百万美元，同比增加31.06%，每股基本收益为-1.28美元。从资产负债表来看，Janux Therapeutics, Inc.总负债38.74百万美元，其中短期债务1.75百万美元，资产负债比为0.28，流动比率为0.60。机构评级：截至2025年3月8日，当前有13家机构对Janux Therapeutics, Inc.目标价做出预测，其中目标均价为86.54美元，其中最低目标价为25.00美元，最高目标价为200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000225abed6693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000225abed6693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","LENZ"],"gpt_icon":0},{"id":"2517694882","title":"Janux Therapeutics, Inc.盘中异动 早盘急速拉升5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517694882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517694882?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:39","pubTimestamp":1741185583,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时39分，Janux Therapeutics, Inc.股票出现波动，股价急速上涨5.47%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223944a260ca65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223944a260ca65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2516589677","title":"Janux Therapeutics, Inc.盘中异动 早盘大幅跳水5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516589677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516589677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098719,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分，Janux Therapeutics, Inc.股票出现异动，股价大幅跳水5.28%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223159a25f0476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223159a25f0476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2516585562","title":"Scotiabank：维持Janux Therapeutics(JANX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由62.00美元调整至41.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516585562","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516585562?lang=zh_cn&edition=full","pubTime":"2025-03-01 07:47","pubTimestamp":1740786423,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Janux Therapeutics(JANX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由62.00美元调整至41.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01074748470501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","JANX"],"gpt_icon":0},{"id":"1136124682","title":"Janux Therapeutics 2024年第四季度GAAP每股收益$(0.36) 超出预期$(0.47)","url":"https://stock-news.laohu8.com/highlight/detail?id=1136124682","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136124682?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:38","pubTimestamp":1740692305,"startTime":"0","endTime":"0","summary":"Janux Therapeutics  报告季度每股亏损$，超出分析师一致预期的$，超过23.4%。相比去年同期每股亏损$，这是一个44%的下降。以上内容来自Benzinga Earnings专栏，原文如下：Janux $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 23.4 percent. This is a 44 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JANX","LENZ"],"gpt_icon":0},{"id":"2513576720","title":"Janux Therapeutics, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513576720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513576720?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:54","pubTimestamp":1740408845,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时54分，Janux Therapeutics, Inc.股票出现波动，股价大幅下跌5.03%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为136.18%、55.56%、25.06%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225406962e9e7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225406962e9e7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","JANX","LENZ"],"gpt_icon":0},{"id":"2509238049","title":"Janux Therapeutics, Inc.盘中异动 早盘急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509238049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509238049?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:44","pubTimestamp":1738770244,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时44分，Janux Therapeutics, Inc.股票出现异动，股价急速拉升5.06%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4054.20%、1197.54%、978.89%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205234405abc38da0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205234405abc38da0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4539","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.januxrx.com","stockEarnings":[{"period":"1week","weight":-0.0203},{"period":"1month","weight":0.1037},{"period":"3month","weight":-0.2151},{"period":"6month","weight":-0.399},{"period":"1year","weight":-0.4192},{"period":"ytd","weight":-0.5228}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0358},{"period":"3month","weight":0.149},{"period":"6month","weight":0.0584},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Janux Therapeutics, Inc.于2017年6月27日在特拉华州注册成立。该公司是一家创新的生物制药公司，开发基于该公司专有的肿瘤激活T细胞接合器（TRACTr）平台技术的下一代疗法，以更好地治疗癌症患者。该公司最初的重点是开发一类新的T细胞接合器（TCE），该公司的主要候选产品是针对临床验证的药物靶点设计的。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.017049},{"month":2,"riseRate":0.5,"avgChangeRate":1.072919},{"month":3,"riseRate":0,"avgChangeRate":-0.210851},{"month":4,"riseRate":0.75,"avgChangeRate":0.173971},{"month":5,"riseRate":0.25,"avgChangeRate":-0.113738},{"month":6,"riseRate":0.5,"avgChangeRate":-0.031968},{"month":7,"riseRate":0.8,"avgChangeRate":0.114342},{"month":8,"riseRate":0.5,"avgChangeRate":-0.033618},{"month":9,"riseRate":0.25,"avgChangeRate":-0.057733},{"month":10,"riseRate":0.75,"avgChangeRate":0.071595},{"month":11,"riseRate":0.25,"avgChangeRate":-0.07955},{"month":12,"riseRate":0.75,"avgChangeRate":0.122141}],"exchange":"NASDAQ","name":"Janux Therapeutics, Inc.","nameEN":"Janux Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Janux Therapeutics, Inc.,JANX,Janux Therapeutics, Inc.股票,Janux Therapeutics, Inc.股票老虎,Janux Therapeutics, Inc.股票老虎国际,Janux Therapeutics, Inc.行情,Janux Therapeutics, Inc.股票行情,Janux Therapeutics, Inc.股价,Janux Therapeutics, Inc.股市,Janux Therapeutics, Inc.股票价格,Janux Therapeutics, Inc.股票交易,Janux Therapeutics, Inc.股票购买,Janux Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}